Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01946126 · ClinicalTrials.gov registry record
A Retrospective Chart Review to Evaluate Diagnosis and Treatment of Chronic Migraine and Headache
A clinical trial, sponsored by Allergan.
- Completed
- Registry status
- 459
- Enrollment target
NCT01946126: Completed study, sponsored by Allergan.
NCT01946126 is a clinical trial that has completed, run by Allergan. The registered enrollment target is 459 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01946126 has completed, sponsored by Allergan.
- COMPLETED
- Registry status
- 459 participants
- Enrollment target
Study Summary
This study is a retrospective chart review in patients diagnosed with headache or migraine to evaluate treatment patterns and diagnosis.
Primary Outcome
The presence or absence of prophylactic medications used by the subject for headache/migraine is evaluated through the study period.
Interventions
- OTHER No Intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 459 participants |
| Start Date | 2014-03 |
| Est. Completion | 2014-04 |
What the finished NCT01946126 record still lists
NCT01946126 is an observational study that tracks outcomes without assigning an intervention. The registered 459 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which No Intervention is the first listed.
NCT01946126 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01946126 about?
NCT01946126 is a clinical study titled "A Retrospective Chart Review to Evaluate Diagnosis and Treatment of Chronic Migraine and Headache". This study is a retrospective chart review in patients diagnosed with headache or migraine to evaluate treatment patterns and diagnosis.
What is the current status of trial NCT01946126?
This trial is currently completed. The enrollment target is 459 participants. The study started on 2014-03. Estimated completion is 2014-04.
What interventions are being tested in trial NCT01946126?
The interventions under investigation include: No Intervention (OTHER).
Who is sponsoring clinical trial NCT01946126?
This trial is sponsored by Allergan, which has 314 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04452825 · 459 participants · NA
A New Psychotherapy Intervention for Older Cancer Patients
- NCT02977780 · 460 participants · Phase 2
INdividualized Screening Trial of Innovative Glioblastoma Therapy (INSIGhT)
- NCT03427736 · 460 participants
Anesthetics and Analgesics in Children
- NCT03819933 · 460 participants · NA
Optimizing Family Counseling for Anticipated Extremely Preterm Delivery
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia